Entity Public Float of Outlook Therapeutics, Inc. from 31 Mar 2016 to 31 Mar 2025

Taxonomy & unit
dei: USD
Description
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Summary
Outlook Therapeutics, Inc. quarterly Entity Public Float in USD history and change rate from 31 Mar 2016 to 31 Mar 2025.
  • Outlook Therapeutics, Inc. Entity Public Float for the quarter ending 31 Mar 2025 was $26,900,000, a 85% decline year-over-year.
Source SEC data
View on sec.gov
Entity Public Float, Quarterly (USD)
Entity Public Float, YoY Quarterly Change (%)

Outlook Therapeutics, Inc. Quarterly Entity Public Float (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $26,900,000 -$153,500,000 -85% 31 Mar 2025 10-K 19 Dec 2025 2025 FY
Q1 2024 $180,400,000 +$900,000 +0.5% 31 Mar 2024 10-K/A 23 Jan 2025 2024 FY
Q1 2023 $179,500,000 -$42,000,000 -19% 31 Mar 2023 10-K/A 24 Jan 2024 2023 FY
Q1 2022 $221,500,000 +$22,000,000 +11% 31 Mar 2022 10-K/A 24 Jan 2023 2022 FY
Q1 2021 $199,500,000 +$179,100,000 +878% 31 Mar 2021 10-K 23 Dec 2021 2021 FY
Q1 2020 $20,400,000 +$1,500,000 +7.9% 31 Mar 2020 10-K 23 Dec 2020 2020 FY
Q1 2019 $18,900,000 +$3,300,000 +21% 29 Mar 2019 10-K 19 Dec 2019 2019 FY
Q1 2018 $15,600,000 -$28,900,000 -65% 30 Mar 2018 10-K 18 Dec 2018 2018 FY
Q1 2017 $44,500,000 +$44,500,000 31 Mar 2017 10-K 29 Dec 2017 2017 FY
Q1 2016 $0 31 Mar 2016 10-K 29 Dec 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.